Table 1 Characteristics of study participants.
From: Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease
Low NAL | High NAL | p | |
---|---|---|---|
Gender (M/F) | 19/46 | 13/22 | 0.419 |
Age (years, mean ± SD) | 77.61 ± 5.55 | 79.22 ± 5.38 | 0.165 |
BMI (mean ± SD) | 27.38 ± 4.47 | 28.05 ± 4.73 | 0.486 |
Education (years, mean ± SD) | 14.86 ± 3.31 | 13.66 ± 2.84 | 0.078 |
Total cholesterol (mmol/L, mean ± SD) | 4.82 ± 0.98 | 4.35 ± 1.19 | 0.045 |
Triglycerides (mmol/L, mean ± SD) | 1.34 ± 0.70 | 1.10 ± 0.42 | 0.071 |
HDL cholesterol (mmol/L, mean ± SD) | 1.64 ± 0.55 | 1.52 ± 0.48 | 0.292 |
LDL cholesterol (mmol/L, mean ± SD) | 2.39 ± 0.85 | 2.34 ± 0.88 | 0.794 |
Testosterone (nmol/L, mean ± SD), males | 14.43 ± 6.16 | 11.66 ± 3.77 | 0.160 |
Testosterone (nmol/L, mean ± SD), females | 1.45 ± 2.55 | 1.26 ± 0.81 | 0.738 |
Oestradiol (pmol/L, mean ± SD), males | 113.16 ± 47.83 | 117.23 ± 35.17 | 0.795 |
Oestradiol (pmol/L, mean ± SD), females | 91.22 ± 118.71 | 73.90 ± 28.97 | 0.523 |
APOE ε4 carriers (%) | 7.69 | 45.71 | 0.00000848 |
MMSE (mean ± SD) | 28.50 ± 1.16 | 28.80 ± 1.10 | 0.225 |
FBB-PET SUVR (mean ± SD) | 1.15 ± 0.08 | 1.71 ± 0.26 | — |
HV% (left; right lobes, mean ± SD) | 0.195 ± 0.020; 0.199 ± 0.021 | 0.194 ± 0.019; 0.199 ± 0.018 | 0.805; 0.890 |